Cargando…

T174. ANTIPSYCHOTICS AND THE MICROBIOME

BACKGROUND: Gut microbial diversity is influenced by many factors including aging and environmental factors and it has an important implication on various physiologic functions and disease processes. Studying microbial communities and its diversity may be used as a predictor or biomarker for disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Anderson, Park, Taeyang, Li, Kevin, Delisi, Lynn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234643/
http://dx.doi.org/10.1093/schbul/sbaa029.734
_version_ 1783535811794305024
author Chen, Anderson
Park, Taeyang
Li, Kevin
Delisi, Lynn
author_facet Chen, Anderson
Park, Taeyang
Li, Kevin
Delisi, Lynn
author_sort Chen, Anderson
collection PubMed
description BACKGROUND: Gut microbial diversity is influenced by many factors including aging and environmental factors and it has an important implication on various physiologic functions and disease processes. Studying microbial communities and its diversity may be used as a predictor or biomarker for disease development. METHODS: In-depth literature review was conducted of literature within the last 5 years via database search of Pubmed, PsycInfo, EMBASE, and Google Scholar with Boolean combinations of the following keywords: antipsychotics AND (microbiome OR “metabolic syndrome”), microbiome AND (gender OR aging). RESULTS: 2,360 articles were initially retrieved. 27 articles remained after excluding for non-English articles and relevance. Notable findings include that patients treated with both risperidone and olanzapine have less diverse microbiomes with a higher ratio of Firmicutes to Bacteroidetes. Additionally, patients treated with olanzapine have been shown to have increased actinobacteria and increased ratio of Firmicutes to Bacteroidetes. The ratio of Firmicutes to Bacteroidetes correlates directly to the extent of olanzapine induced weight gain. Patients concurrently treated with olanzapine and antibiotics not only stopped weight gain but also reversed it. This has been a target of potential medication intervention, specifically focused on antagonism of histamine-1 and -3 receptors which is speculated to inhibit the askewed Firmicutes to Bacteroidetes ratio. Similarly, the gender differences in relative microbiome levels of Bacteroidetes are suspected to correlate to the increased olanzapine induced weight gain seen in women versus men. Additionally, patients with schizophrenia who were treated with Bifidobacterium breve A1, a probiotic supplement, showed improvements in their affective, positive, and negative symptoms. DISCUSSION: There is a large paucity of research into the relationship between the microbiome and psychotropic medications. This dynamic should be further studied within multiple populations to better understand the gut biome’s effects on psychiatric disorders.
format Online
Article
Text
id pubmed-7234643
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72346432020-05-23 T174. ANTIPSYCHOTICS AND THE MICROBIOME Chen, Anderson Park, Taeyang Li, Kevin Delisi, Lynn Schizophr Bull Poster Session III BACKGROUND: Gut microbial diversity is influenced by many factors including aging and environmental factors and it has an important implication on various physiologic functions and disease processes. Studying microbial communities and its diversity may be used as a predictor or biomarker for disease development. METHODS: In-depth literature review was conducted of literature within the last 5 years via database search of Pubmed, PsycInfo, EMBASE, and Google Scholar with Boolean combinations of the following keywords: antipsychotics AND (microbiome OR “metabolic syndrome”), microbiome AND (gender OR aging). RESULTS: 2,360 articles were initially retrieved. 27 articles remained after excluding for non-English articles and relevance. Notable findings include that patients treated with both risperidone and olanzapine have less diverse microbiomes with a higher ratio of Firmicutes to Bacteroidetes. Additionally, patients treated with olanzapine have been shown to have increased actinobacteria and increased ratio of Firmicutes to Bacteroidetes. The ratio of Firmicutes to Bacteroidetes correlates directly to the extent of olanzapine induced weight gain. Patients concurrently treated with olanzapine and antibiotics not only stopped weight gain but also reversed it. This has been a target of potential medication intervention, specifically focused on antagonism of histamine-1 and -3 receptors which is speculated to inhibit the askewed Firmicutes to Bacteroidetes ratio. Similarly, the gender differences in relative microbiome levels of Bacteroidetes are suspected to correlate to the increased olanzapine induced weight gain seen in women versus men. Additionally, patients with schizophrenia who were treated with Bifidobacterium breve A1, a probiotic supplement, showed improvements in their affective, positive, and negative symptoms. DISCUSSION: There is a large paucity of research into the relationship between the microbiome and psychotropic medications. This dynamic should be further studied within multiple populations to better understand the gut biome’s effects on psychiatric disorders. Oxford University Press 2020-05 2020-05-18 /pmc/articles/PMC7234643/ http://dx.doi.org/10.1093/schbul/sbaa029.734 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Session III
Chen, Anderson
Park, Taeyang
Li, Kevin
Delisi, Lynn
T174. ANTIPSYCHOTICS AND THE MICROBIOME
title T174. ANTIPSYCHOTICS AND THE MICROBIOME
title_full T174. ANTIPSYCHOTICS AND THE MICROBIOME
title_fullStr T174. ANTIPSYCHOTICS AND THE MICROBIOME
title_full_unstemmed T174. ANTIPSYCHOTICS AND THE MICROBIOME
title_short T174. ANTIPSYCHOTICS AND THE MICROBIOME
title_sort t174. antipsychotics and the microbiome
topic Poster Session III
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234643/
http://dx.doi.org/10.1093/schbul/sbaa029.734
work_keys_str_mv AT chenanderson t174antipsychoticsandthemicrobiome
AT parktaeyang t174antipsychoticsandthemicrobiome
AT likevin t174antipsychoticsandthemicrobiome
AT delisilynn t174antipsychoticsandthemicrobiome